{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33082832", "DateRevised": {"Year": "2020", "Month": "10", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "07"}], "Language": ["eng"], "ELocationID": ["8592869", "10.1155/2020/8592869"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "A Randomized, Triple-Blind, Placebo-Controlled, Add-On Clinical Trial to Evaluate the Efficacy of <i>Emblica officinalis</i> in Uncontrolled Hypertension.", "Pagination": {"StartPage": "8592869", "MedlinePgn": "8592869"}, "Abstract": {"AbstractText": ["<i>Introduction. Emblica officinalis</i> (EO) has some cardiovascular effects, and there are some animal studies that show its antihypertensive effect. This study was conducted to determine the effect of combination of EO with standard therapy on the systolic blood pressure (SBP) and diastolic blood pressure (DBP) in patients with uncontrolled hypertension. <i>Materials and Methods.</i> This was a randomized, triple-blind, placebo-controlled, 8-week study. Ninety-two patients with uncontrolled hypertension despite taking hypotensive drugs were randomly assigned into two groups to take EO (500\u2009mg/TDS after meal) or placebo in combination with standard antihypertensive drugs. After 2, 4, 6, and 8 weeks of intervention, SBP and DBP and heart rate (HR) were measured. Data were analyzed by SPSS software using repeated measures ANOVA. <i>Results.</i> Eighty-one patients (41 in the drug group and 40 in the placebo group) completed the study for 8 weeks and were analyzed. The mean\u2009\u00b1\u2009standard deviation of age was 53.64\u2009\u00b1\u200910.01 years. SBP decreased as 15.6\u2009\u00b1\u20098.23% in the EO group and 6.3\u2009\u00b1\u20097.49% in the placebo group (<i>P</i> < 0.001). DBP decreased as 12.3\u2009\u00b1\u20097.87% and 3.88\u2009\u00b1\u20097.98%, respectively (<i>P</i> < 0.001). Time effect was not significant, but the group effect was significant (<i>F</i>\u2009=\u200913.875, <i>P</i>=0.001 for systolic BP and <i>F</i>\u2009=\u200918.948, <i>P</i> < 0.001 for diastolic BP). No side effects were reported during the study. <i>Conclusion.</i> Eight-week combination therapy of EO with standard antihypertensive drugs significantly reduced the SBP and DBP more than placebo in patients with uncontrolled hypertension."], "CopyrightInformation": "Copyright \u00a9 2020 Samad Ghaffari et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ghaffari", "ForeName": "Samad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Islamic and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Navabzadeh", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran."}], "LastName": "Ziaee", "ForeName": "Mojtaba", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Islamic and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Ghobadi", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Islamic and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Ghods", "ForeName": "Roshanak", "Initials": "R"}, {"Identifier": ["0000-0003-0005-5792"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Islamic and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Hashem-Dabaghian", "ForeName": "Fataneh", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bromfield S., Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Current Hypertension Reports. 2013;15(3):134\u2013136. doi: 10.1007/s11906-013-0340-9.", "ArticleIdList": ["10.1007/s11906-013-0340-9", "PMC3699411", "23536128"]}, {"Citation": "Lotfaliany M., Akbarpour S., Mozafary A., Boloukat R. R., Azizi F., Hadaegh F. Hypertension phenotypes and incident cardiovascular disease and mortality events in a decade follow-up of a middle East cohort. Journal of Hypertension. 2015;33(6):1153\u20131161. doi: 10.1097/hjh.0000000000000540.", "ArticleIdList": ["10.1097/hjh.0000000000000540", "25699976"]}, {"Citation": "Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J. Global burden of hypertension: analysis of worldwide data. The Lancet. 2005;365(9455):217\u2013223. doi: 10.1016/s0140-6736(05)17741-1.", "ArticleIdList": ["10.1016/s0140-6736(05)17741-1", "15652604"]}, {"Citation": "Mirzaei M., Moayedallaie S., Jabbary L., Mohammadi M. Prevalence of hypertension in Iran 1980\u20132012: a systematic review. Journal of Tehran University Heart Center. 2016;11(4):159\u2013167.", "ArticleIdList": ["PMC5424849", "28496506"]}, {"Citation": "Mohsenzadeh Y., Motedayen M., Sayehmiri K., Sarokhani M. T., Sarokhani D. Investigating the prevalence rate of hypertension in Iranian men and women: a study of systematic review and meta-analysis. Journal of Basic Research in Medical Sciences. 2017;4(1):53\u201362. doi: 10.18869/acadpub.jbrms.4.1.53.", "ArticleIdList": ["10.18869/acadpub.jbrms.4.1.53"]}, {"Citation": "Stamler J., Stamler R., Neaton J. D. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Archives of Internal Medicine. 1993;153(5):598\u2013615. doi: 10.1001/archinte.153.5.598.", "ArticleIdList": ["10.1001/archinte.153.5.598", "8439223"]}, {"Citation": "Lim S. S., Vos T., Flaxman A. D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2224\u20132260.", "ArticleIdList": ["PMC4156511", "23245609"]}, {"Citation": "Kontis V., Mathers C. D., Bonita R., et al. Regional contributions of six preventable risk factors to achieving the 25\u2009\u00d7\u200925 non-communicable disease mortality reduction target: a modelling study. The Lancet Global Health. 2015;3(12):e746\u2013e757. doi: 10.1016/s2214-109x(15)00179-5.", "ArticleIdList": ["10.1016/s2214-109x(15)00179-5", "26497599"]}, {"Citation": "Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update. Circulation. 2007;115(5):e69\u2013e171. doi: 10.1161/circulationaha.106.179918.", "ArticleIdList": ["10.1161/circulationaha.106.179918", "17194875"]}, {"Citation": "Ernst E. Complementary/alternative medicine for hypertension: a mini-review. Wiener Medizinische Wochenschrift. 2005;155(17-18):386\u2013391. doi: 10.1007/s10354-005-0205-1.", "ArticleIdList": ["10.1007/s10354-005-0205-1", "16392435"]}, {"Citation": "Khan K. H. Roles of Emblica officinalisin medicine-a review. International Journal of Botany and Research. 2009;2(4):218\u2013228."}, {"Citation": "Ghorbani F., Nazem E., Imani A., Faghihi M., Keshavarz M. Cardiotonic drugs from the Avicenna\u2019s point of view. Iranian Journal of Public Health. 2015;44(1):153\u2013154.", "ArticleIdList": ["PMC4450009", "26060793"]}, {"Citation": "Hashem-Dabaghian F., Ziaee M., Ghaffari S., Nabati F., Kianbakht S. A systematic review on the cardiovascular pharmacology of Emblica officinalis Gaertn. Journal of Cardiovascular and Thoracic Research. 2018;10(3):118\u2013128. doi: 10.15171/jcvtr.2018.20.", "ArticleIdList": ["10.15171/jcvtr.2018.20", "PMC6203864", "30386531"]}, {"Citation": "Bhatia J., Tabassum F., Sharma A. K., et al. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovascular Toxicology. 2011;11(3):272\u2013279. doi: 10.1007/s12012-011-9122-2.", "ArticleIdList": ["10.1007/s12012-011-9122-2", "21748534"]}, {"Citation": "Patel S. S., Goyal R. K. Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit. Experimental and Clinical Cardiology. 2011;16(3):87\u201391.", "ArticleIdList": ["PMC3209545", "22065939"]}, {"Citation": "Gopa B., Bhatt J., Hemavathi K. G. A comparative clinical study of hypolipidemic efficacy of amla (Emblica officinalis) with 3-hydroxy-3-methylyglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian Journal of Pharmacology. 2012;44(2):238\u2013242.", "ArticleIdList": ["PMC3326920", "22529483"]}, {"Citation": "Srivastava R. Efficacy of Amla Powder (Emblica Officinalis) and Nutrition Counselling on Hyperlipidemic and Hypertensive Subjects. Punjab, Ludhiana, India: Agricultural University; 2009."}, {"Citation": "James P. A., Oparil S., Carter B. L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults. Journal of the American Medical Association. 2014;311(5):507\u2013520. doi: 10.1001/jama.2013.284427.", "ArticleIdList": ["10.1001/jama.2013.284427", "24352797"]}, {"Citation": "Andrade S. E., Kahler K. H., Frech F., Chan K. A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug Safety. 2006;15(8):565\u2013574. doi: 10.1002/pds.1230.", "ArticleIdList": ["10.1002/pds.1230", "16514590"]}, {"Citation": "Aghili Khorasani M. Makhzan Al-Advieh. Tehran, Iran.: Sabzara press; 2011."}, {"Citation": "Usharani P., Fatima N., Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2013;6:275\u2013284. doi: 10.2147/DMSO.S46341.", "ArticleIdList": ["10.2147/DMSO.S46341", "PMC3735284", "23935377"]}, {"Citation": "Fatima N., Pingali U., Pilli R. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy subjects. Pharmacognosy Research. 2014;6(1):29\u201335.", "ArticleIdList": ["PMC3897005", "24497739"]}, {"Citation": "Erlund I., Koli R., Alfthan G., et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. The American Journal of Clinical Nutrition. 2008;87(2):323\u2013331. doi: 10.1093/ajcn/87.2.323.", "ArticleIdList": ["10.1093/ajcn/87.2.323", "18258621"]}, {"Citation": "Vita J. A. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. The American Journal of Clinical Nutrition. 2005;81:s292\u2013s297. doi: 10.1093/ajcn/81.1.292s.", "ArticleIdList": ["10.1093/ajcn/81.1.292s", "15640493"]}, {"Citation": "Mathur R., Sharma A., Dixit V. P., Varma M. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. Journal of Ethnopharmacology. 1996;50(2):61\u201368. doi: 10.1016/0378-8741(95)01308-3.", "ArticleIdList": ["10.1016/0378-8741(95)01308-3", "8866725"]}, {"Citation": "Thakur C. P., Thakur B., Singh S., Sinha P. K., Sinha S. K. The Ayurvedic medicines Haritaki, Amla and Bahira reduce cholesterol-induced atherosclerosis in rabbits. International Journal of Cardiology. 1988;21(2):167\u2013175. doi: 10.1016/0167-5273(88)90219-7.", "ArticleIdList": ["10.1016/0167-5273(88)90219-7", "3225068"]}, {"Citation": "Antony B., Merina B., Sheeba V., Mukkadan J. Effect of standardizedAmlaextract on atherosclerosis and dyslipidemia. Indian Journal of Pharmaceutical Sciences. 2006;68(4):437\u2013441. doi: 10.4103/0250-474x.27814.", "ArticleIdList": ["10.4103/0250-474x.27814"]}, {"Citation": "Harrison D. G., Gongora M. C. Oxidative stress and hypertension. Medical Clinics of North America. 2009;93(3):621\u2013635. doi: 10.1016/j.mcna.2009.02.015.", "ArticleIdList": ["10.1016/j.mcna.2009.02.015", "19427495"]}, {"Citation": "Loperena R., Harrison D. G. Oxidative stress and hypertensive diseases. Medical Clinics of North America. 2017;101(1):169\u2013193. doi: 10.1016/j.mcna.2016.08.004.", "ArticleIdList": ["10.1016/j.mcna.2016.08.004", "PMC5125524", "27884227"]}, {"Citation": "Khopde S. M., Indira Priyadarsini K., Mohan H., et al. Characterizing the antioxidant activity of amla (Phyllanthus emblica) extract. Current Science. 2001;81(2):185\u2013190."}, {"Citation": "Narasimhacharya A., Vasant R. A., Prajapati P. C. Angiotensin-converting enzyme inhibition by certain fruits: an in vitro study. Current Trends in Biotechnology and Pharmacy. 2010;4(3):801\u2013808."}, {"Citation": "Sohgaura A., Bigoniya P., Shrivastava B. Diuretic potential of cynodon dactylon, emblica officinalis, kalanchoe pinnata and bambusa nutans. Journal of Pharmacognosy and Phytochemistry. 2018;7(3):2895\u20132900."}]}], "History": [{"Year": "2020", "Month": "3", "Day": "17"}, {"Year": "2020", "Month": "7", "Day": "11"}, {"Year": "2020", "Month": "9", "Day": "23"}, {"Year": "2020", "Month": "10", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["33082832", "PMC7563076", "10.1155/2020/8592869"]}}]}